Tumor spread, in general, is the most important factor determining outcome in almost all malignant tumors. Lung tumors are unique with respect to potential routes for tumor dissemination, as apart from vascular, nodal, and distant spread of tumor cells, tumor spread through air spaces (STAS) might also occur. However, morphologic criteria for STAS and its prognostic impact have not been defined yet. We evaluated a series of 569 resected pulmonary adenocarcinomas (ADCs) for predefined morphologic criteria of limited and extensive STAS and correlated our findings with clinical, morphologic, molecular, and outcome data. Limited (21.6%) or extensive (29%) STAS was present in roughly half of all ADCs. The presence and type of STAS was tightly linked to specific growth patterns (P < 0.001). STAS was much more prevalent in high-stage (P < 0.001), nodal-positive (P < 0.001) ADC with distant metastasis (P = 0.010). STAS was associated with lower rates of EGFR (P = 0.009) but higher rates of BRAF (P = 0.016) mutations. Furthermore, STAS was associated with significantly reduced overall (P = 0.020) and diseasefree survival (P = 0.004), which was growth pattern but not stage independent. We analyzed morphologic characteristics of a yet underestimated type of tumor spread of pulmonary ADC through air spaces. STAS is a novel morphologic prognosticator, which should be further validated and considered for implementation in routine diagnostic evaluation and reporting.
C omprehensive clinicopathologic characterization of pulmonary adenocarcinomas (ADCs) by means of morphology, immunohistochemistry, and molecular analyses have revealed multiple prognostic and predictive features resulting in a multidisciplinary classification of this entity in 2011, 1 which constitutes one of the backbones of current patient stratification and therapeutic decision making.
With respect to morphology, the semiquantitative assessment of different growth patterns in pulmonary ADC has been demonstrated as a stage-independent predictor of survival. The different patterns have also been associated with specific molecular alterations. [2] [3] [4] [5] Further studies expanded the concept of the 5 initially defined predominant patterns by adding the cribriform pattern, which has a distinct prognostic relevance. [6] [7] [8] However, beyond the specific growth patterns of pulmonary ADC, there are clearly other morphologic characteristics associated with the biology and clinical outcome of pulmonary ADC patients. In many ADCs, a peripheral cell detachment and subsequent intra-alveolar spread of tumor cell nests or single tumor cells is evident at the circumferential tumor edge, which may result in formation of satellite tumor nodules and thus more rapid tumor expansion within the lungs. First data point toward a potential association of a tumor spread through air spaces (STAS) and formation of detached tumor islands with a worse outcome in pulmonary ADC. 9 However, this has not been assessed and validated systematically in larger cohorts yet.
To further determine the prognostic impact of STAS in pulmonary ADC, we analyzed a well-characterized cohort of 569 surgically resected tumors with clinical data including overall (OS) and disease-free survival (DFS).
PATIENTS AND METHODS

Cohort
Our initial case collection included 674 completely resected ADCs, which were surgically treated between 2002 and 2010 at the Thoraxklinik at Heidelberg University. As the respective diagnostic slides were not prepared to specifically assess the question of STAS, we had to define minimal quality criteria, which ensured that tumor spread could be reliably evaluated in a given case. We decided only to include cases in which the tumor periphery adjacent to normal lung was present in at least 1 full slide section with an uninterrupted semicircumferential tumor edge. This resulted in a final cohort of 569 cases.
Of these, 11 patients (1.9%) were treated with wedge resection, 7 patients (1.2%) received segmentectomy, 472 patients (83%) received lobectomy, 13 patients (2.3%) received bilobectomy, and 66 patients (11.6%) were treated with pneumonectomy. The mean age at the time of diagnosis was 62.8 years. Three hundred thirtythree (58.5%) patients were male, 236 (41.5%) patients were female. All tumors were classified according to the IASLC/ATS/ERS classification 1 under inclusion of the cribriform pattern and staged according to the seventh edition of the tumor, node, metastasis system. Specific subtypes of ADC (eg, invasive mucinous ADC, ADC in situ, and minimally invasive ADC) were excluded from analysis. None of the patients were treated with neoadjuvant radiotherapy and/or chemotherapy. One hundred sixty-two (28.5%) patients received adjuvant chemotherapy following the guidelines in effect at the time of diagnosis; 108 (19%) patients received adjuvant mediastinal radiation. One hundred ninety-five (34.3%) patients died during follow-up; 228 (40.1%) relapsed. The mean follow-up time of patients alive at the endpoint of analysis was 37.8 months; the mean follow-up time of patients without recurrence at the endpoint of analysis was 32.5 months. Data on smoking habits were available for 290 patients (51%). Of these, 262 (90.3%) were smokers. Distribution of important clinicopathologic variables is given in Table 1 .
Definition of Tumor STAS
We defined STAS as a detachment of small solid cell nests (at least 5 tumor cells) <3 alveolae away from the main tumor mass as limited STAS and tumor cell nests >3 alveolae away from the main tumor mass as extensive STAS. To avoid confusion with artificially detached cells during tumor dissection, tumor cells were only considered if they were arranged in loose small groups, and the distribution was consistent with the overall configuration of the circumferential tumor edge. We only scored tumor cells as STAS when there was no direct connection of the cells to the main tumor mass ( Fig. 1 ). Solid-predominant ADC or tumors showing scarring at the circumferential tumor edge usually allowed for a very easy and clear-cut assessment; in all other tumors we drew an idealized usually slightly curved line along the most peripheral coherent tumor cell formations. Cell nests outside this line were considered as STAS when no contact to the main tumor mass was evident.
Immunohistochemistry and Molecular Analyses
Immunohistochemical analyses of diagnostic (TTF1, napsin, CK7) and prognostic (Ki-67) markers as well as mutation analyses of KRAS, EGFR, BRAF and translocation analyses of ALK and ROS1 were performed as described previously in detail. 4,10-12
RESULTS
Association of STAS With Growth Patterns
We found that 123 of our 569 cases (21.6%) showed limited STAS, whereas 165 (29%) cases had extensive STAS. The remaining 281 cases (49.4%) did not show STAS.
The presence of STAS was tightly linked to the predominant growth pattern of ADC (P < 0.001). Whereas STAS was exceedingly rare in lepidic-predominant ADC, all other predominant growth patterns were associated-at least to some extent-with STAS. However, the type of spread was different (Fig. 2 ). An association was seen between 46.2% of acinar-predominant ADC and both limited (17.9%) and extensive (28.3%) STAS. Papillary-predominant ADC had a comparable rate of STAS (56.2%); however, STAS was rather extensive (46.1%) than limited (10.1%). Micropapillarypredominant ADC showed the highest rate of STAS (91.3%), which was predominantly extensive (80.4%). Solid-predominant and cribriform-predominant ADCs showed STAS in roughly half of the cases (cribriform: 57.7%, solid: 47.3%); however, these patterns had a considerably different distribution of STAS type with a predominance for limited spread (cribriform: 46.2%, solid: 31.1%) ( Table 1 , Fig. 2 ).
Association of STAS With Clinicopathologic Variables
STAS was significantly more likely (P = 0.002) to occur in male than in female patients ( Table 1) . Furthermore, the presence of STAS was tightly linked to the presence of nodal (P < 0.001) and distant (P = 0.010) metastasis and, thus, consequently also to tumor stage (P < 0.001; Fig. 2 , Table 1 ). Smoking habits were not associated with STAS.
Association of STAS With Immunophenotype, Proliferation, and Molecular Tumor Makeup
Data on diagnostic immunomarkers were present for at least 392 cases of our final cohort from a previous study. 12 The presence of STAS was not associated with expression of TTF1, napsin, or CK7 (data not shown). Data on proliferative activity (Ki-67) were available for 527 cases, again from a previous study. 10 Cases with STAS were not significantly different from cases without STAS with respect to proliferative activity (Table 1) . We had data on molecular profiles for 333 cases of our cohort. 4 
Association of STAS With Survival
The presence of both limited and extensive STAS was associated with reduced OS and DFS. However, patients whose tumors showed limited STAS and patients whose tumors had extensive STAS had virtually the same survival times. OS dropped from 71.1 months for patients without STAS to 59.1 months for patients with limited STAS and 54.2 months for patients with extensive STAS (P = 0.020). This was mirrored by similar differences in DFS (no STAS: 63.1 mo; limited STAS: 48.9 mo; extensive STAS: 45.6 mo; P = 0.004) ( Table 2 , Fig. 3 ).
When we stratified our cases for different predominant growth patterns and investigated the survival impact of STAS in each of the subgroups, we found that to a certain degree the reduction of survival in STAS-positive cases was present in all groups. However, we also noted that the impact of STAS on survival was specifically prominent in papillary-predominant and micropapillarypredominant ADC (Fig. 4) .
Finally, we aimed to investigate the prognostic significance of STAS in multivariate models to account for putative dependencies. First, we included both growth pattern and presence of STAS in a multivariate Cox regression model. We found that STAS in addition to pattern (P = 0.002 for both OS and DFS) constitutes a patternindependent predictor of OS (hazard ratio (HR): 1.44, confidence interval: 1.08-1.94; P = 0.014) and DFS (HR: 1.43, confidence interval: 1.09-1.88; P = 0.010). However, when we included stage together with STAS in a multivariate Cox model, we found that stage independency of STAS was neither present for OS (HR: 1.23, P = 0.143) nor for DFS (HR: 1.20, P = 0.225). Stage itself was a highly prognostic STAS-independent parameter in this setting (P < 0.001 for both OS and DFS).
DISCUSSION
We systematically analyzed the prognostic impact of STAS in a large, well-characterized cohort of ADC. We demonstrated that STAS is tightly linked to the predominant growth pattern of ADC, the presence of nodal and distant metastasis, tumor stage, and poor survival.
In preceding studies, a classification of non-small cell lung cancer based on the "biological behavior" of a tumor at the invasion front was proposed, including 3 possible scenarios: (1) preservation of lung tissue and use of its microenvironment for further growth; (2) destruction of lung tissue and formation of a new microenvironment for continued expansion; and (3) preservation of lung tissue and formation of a new microenvironment. This simple categorization was shown to have prognostic impact, pointing out that characteristics of ADC at the invasion front can be used for an optimized morphology-based prognostic patient stratification. [13] [14] [15] Onozato et al 9 recently described the prognostic relevance of so-called tumor islands in a series of 261 early-stage ADCs. Tumor islands were defined as a detached collection of tumor cells within alveolar spaces separated from the main tumor mass by a distance of at least a few alveoli. In their definition, they included only those tumor cell nests that could not be classified as micropapillary growth per se. 16, 17 ADCs with tumor islands were more likely to occur in smokers, showed more likely predominant solid or micropapillary growth patterns, and harbored more KRAS mutations. ADCs without tumor islands were more likely to show lepidic growth and harbored higher rates of EGFR mutations. There was no association of the presence/absence of tumor islands with stage. The 5-year DFS for ADC with and without tumor islands was 44.6% and 74.4%, respectively (P = 0.010), and the survival difference remained significant in multivariate analyses. The presence of tumor islands was associated with an almost 2fold higher risk for recurrence. 9 Of note, on the basis of 3dimensional reconstruction data at least some of such tumor islands are obviously interconnected with each other and with the main tumor mass, which can be recognized by 2dimensional routine examination of histologic slides. 18 Although our concept of STAS assessment was slightly different to the definition of tumor islands used by Onozato and colleagues, we could confirm that spread of tumor cells through air spaces is associated with specific growth patterns, low EGFR mutation rates, and poor OS and DFS. The fact that there was no significant difference between a limited and an extensive STAS with respect to survival in our study suggests that loss of cell adherence at the tumor edge per se may be a novel yet underestimated type of tumor spread, which might have clinical consequences comparable to nodal and distant organ tumor dissemination. However, this has to be validated in future studies on independent large and well-characterized pulmonary ADC cohorts.
The mechanisms underlying intra-alveolar lung cancer spread are largely unknown. According to our data no association with tumor proliferation was evident. As we found a strong correlation of STAS with lymph node and distant metastasis, similar molecular mechanisms or tumor cell properties may be involved. First data point to complex tumor-microenvironment interactions, including the involvement of the laminin 5-integrin-focal adhesion kinase pathway with activation of EGFR signaling 19 and remodeling of the alveolar capillary endothelium 20 but potentially also altered expression of adhesion molecules. 21 Furthermore, there is evidence that neutrophils might promote aerogenous spread of ADC by inducing tumor cell detachment mediated by signals through cell-to-cell contact. 22 Analyses of the tumor-microenvironment at the invasion front of squamous cell carcinomas of the lung also indicate that the inflammatory response to lung tumors may contribute to tumor spread. 23 Further multilevel studies on tumor-host interactions will be an important issue to narrow-in on additional underlying biological mechanisms of STAS.
Limitations of our study are clearly related to its retrospective nature. Although surgical pathology dissection of ADC should always include at least 1 slide showing circumferential tumor edges adjacent to lung parenchyma, naturally a standardized assessment of STAS was not in the focus at the time the cases of our study were prepared for diagnostic purposes. Optimized assessment of STAS will require a more standardized macroscopic and histologic preparation of the circumferential tumor edge. Further, a definition of standards is also needed for other potentially confounding "technical" issues such as fixation times and procedures used for lung tumor specimen workup. Clearly, additional studies, which focus on these topics, are needed.
Besides these technical limitations, there are also limitations that are related to the optimal definition criteria for STAS. First, one might argue about the definition of solid cell nests/tumor islands specifically in the distinction from (micro-)papillary structures floating within alveolae near the circumferential tumor edge. While the delineation of STAS from papillary structures in our experience was feasible, a clear-cut separation of micropapillae from cell nests of STAS may be arbitrary in some instances. However, the fact that a separation in general might be possible and also of importance is indicated by the additional prognostic impact of STAS in micropapillary-predominant ADC in our cohort (cases without STAS were associated with a 100% survival). Therefore, we believe that the delineation of true STAS from micropapillae at a somewhat "ragged" tumor border is feasible and may harbor prognostic information. Second, as with any biological process, we acknowledge that there is a continuum in the evolution of STAS from a single detached cell up to a multitude of solid cell nests surrounding the main tumor mass. However, before STAS could be introduced as a clinically useful prognosticator in the routine diagnostic context, the optimal combination of "cutoff" criteria (nest size, number of cell nests, distance of cell nests from the main tumor mass, others), which define a case as "STAS-positive," must be further refined. Our study clearly just constitutes a starting point in this regard, and additional international studies are essential to substantiate our findings.
Taken together, we defined and clinically validated the characteristics of a yet underestimated type of tumor spread of pulmonary ADCs through air spaces. Intra-alveolar tumor spread represents a novel morphologic criterion that is associated with defined histomorphologic growth patterns, distinct molecular alterations, and the presence of lymph node and distant metastasis and significantly correlates with poor OS and DFS.
